Our mission is to transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those in greatest need.
Amryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing and commercialising innovative treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a strong and growing portfolio of commercial and development assets.
A core belief at Amryt Pharma is that we operate on a foundation of responsibility, integrity and ethical practice. We aim to forge partnerships and collaborations that work for all. By listening to our stakeholders and most importantly our patients, we create a clear path for our transformative medicines to reach those that need them.
Amryt is dedicated purely to rare diseases. Our leadership team all have strong heritage in rare diseases, and it is through bringing them together that we are able to commit completely to delivering medicines that are truly transformative for people with rare, debilitating illnesses.
Our exceptional team offers a wealth of experience in identifying, commercialising and delivering new treatments across global markets. Our ability to navigate diverse regulatory and reimbursement environments, combining a ‘think global, act local approach’, positions us optimally to deliver our goals and get our life changing medicines to all those who need them.